Clinical Trials Directory

Trials / Completed

CompletedNCT05215444

Evaluation of Some Prognostic Factors in Acute Aluminum Phosphide Intoxicated Cases

Status
Completed
Phase
Study type
Observational
Enrollment
42 (actual)
Sponsor
Zagazig University · Other Government
Sex
All
Age
15 Years – 45 Years
Healthy volunteers
Accepted

Summary

study of some laboratory and clinical findings which may show the severity of aluminium phosphide toxicity and the need of the cases to be admitted to ICU

Detailed description

aluminium phosphide poisoning is a major cause of death in intoxicated and suicidal cases since there is no antidote and there is no specific investigation for it so there is a need for further study to identify the cause of death and the most specific investigation in the case of AlP toxicity

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTsome prognostic factorscortisol level, renin, troponin I, MDA ,catalase, super oxide dismutase, liver functions, kidney functions, arterial blood gases, sodium level, potassium level. white blood cells count

Timeline

Start date
2021-01-01
Primary completion
2021-01-30
Completion
2021-06-30
First posted
2022-01-31
Last updated
2023-01-26

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05215444. Inclusion in this directory is not an endorsement.

Evaluation of Some Prognostic Factors in Acute Aluminum Phosphide Intoxicated Cases (NCT05215444) · Clinical Trials Directory